Bharat Biotech wants to sell vaccine at a higher price to invest money in R&D and it is completely justified
Throughout the Coronavirus pandemic, India emerged as the saviour of the world first by supplying Hydroxychloroquine (HCQ) to countries around the world and then by coming up with a low-cost traditional vaccine, developed...